Post by National Cancer Centre Singapore

❓What’s new in cancer Immunotherapeutics? Find out from Associate Professor Li Tang of École Polytechnique Fédérale de Lausanne (EPFL) as he shares new discoveries from his team that shed light on exciting novel strategies to harness Type 2 immunity in the next generation of cancer immunotherapies. 🙌